Lactobacillus acidophilus VB1 co-aggregates and inhibits biofilm formation of chronic otitis media-associated pathogens

Keyphrases

• Otitis Media 100%
• Biofilm Formation 100%
• Co-aggregate 100%
• Lactobacillus Acidophilus 100%
• Ciprofloxacin 40%
• Pathogenic Bacteria 30%
• Cell-free Supernatant 30%
• Antibiofilm 20%
• Biosurfactant 20%
• Antibiotics 10%
• Alternative Therapeutics 10%
• Sham 10%
• Bacterial Biofilm 10%
• Incubation 10%
• Commercially Available 10%
• Staphylococcus Aureus 10%
• Bacterial Species 10%
• Antimicrobial Activity 10%
• Antibacterial Activity 10%
• Iraq 10%
• Klebsiella Pneumoniae (K. pneumoniae) 10%
• Bacterial Ear Infections 10%
• Antagonistic Effect 10%
• Pseudomonas Aeruginosa (P. aeruginosa) 10%
• Associated Bacteria 10%
• Minimum Inhibitory Concentration 10%
• Antibiotic Susceptibility Testing 10%
• Synergistic Activity 10%
• Proteus Mirabilis 10%
• Coaggregation 10%
• Lactobacillus Plantarum 10%
• Medical Laboratory 10%
• Lactobacillus Species 10%
• Checkerboard Assay 10%
• Biofilm Inhibition 10%
• Probiotic Products 10%
• Vitek 2 System 10%
• Bacterial Identification 10%
• Antibacterial Biofilm 10%
• Lactiplantibacillus 10%

Immunology and Microbiology

• Infectious Agent 100%
• Biofilm 100%
• Otitis Media 100%
• Lactobacillus acidophilus 100%
• Lactobacillus 20%
• Probiotic 20%
• Klebsiella pneumoniae 20%
• Antimicrobial Activity 20%
• Minimum Inhibitory Concentration 20%
• Staphylococcus Aureus 20%
• Antibacterial Activity 20%
• Pseudomonas aeruginosa 20%
• Antibiotic Susceptibility Testing 20%
• Lactobacillus plantarum 20%
• Inhibitory Concentration 20%
• Proteus mirabilis 20%
• Otitis 20%
• Bacterium Identification 20%
• Antimicrobial Agent 20%